January 4, 2021 10:29 AM EST

Charles River bags antibody discovery-focused Distribution Bio for $104M, signaling return to pre-pandemic buyout spree

Charles River Labs, one of the biggest CROs that specializes in preclinical research programs, has inked a new discovery pact as part of a string …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Charles Riv­er bags an­ti­body dis­cov­ery-fo­cused Dis­tri­b­u­tion Bio for $104M, sig­nal­ing re­turn to pre-pan­dem­ic buy­out spree